The market capitalization of AIM stocks reached £103bn as of 13th January 2023 compared to the 15th of December 2022. Among the top YTD winners, there were Genincode Plc (+100% YTD on approval of California State licensing approval and CLIA certification of its Irvine laboratory in California, enabling the provision of its products for the risk assessment of CVD to patients across 49 states in the US), Quantum Blockchain Technologies (86.7% on successful legal claim resolution), musicMagpie (66.1% on a positive trading update and products availability on Walmart.com). Among the bottom movers were Parsley Box, Joules Group, and Thinksmart Limited on the cancellation of the admission to trading on AIM; Frontier Developments (-53.0% on weak FY23 outlook), Pelatro (-42.2% on lower-than-expected 2022 performance), and Belluscura (-39.7% on expectations of a bigger financial loss). Sector-wide, the AIM stocks from Utilities, Real estate, Healthcare, Technology, Industrials, and Financials demonstrated a positive price move (weighted average) YTD as of 13/01/2023, compared to all-positive average returns by sector for FTSE 350 peers.
